Department of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, Arizona, United States of America.
PLoS One. 2012;7(6):e39818. doi: 10.1371/journal.pone.0039818. Epub 2012 Jun 22.
Glioblastoma (GB) is the most common and lethal type of primary brain tumor. Clinical outcome remains poor and is essentially palliative due to the highly invasive nature of the disease. A more thorough understanding of the molecular mechanisms that drive glioma invasion is required to limit dispersion of malignant glioma cells.
METHODOLOGY/PRINCIPAL FINDINGS: We investigated the potential role of differential expression of microRNAs (miRNA) in glioma invasion by comparing the matched large-scale, genome-wide miRNA expression profiles of migrating and migration-restricted human glioma cells. Migratory and migration-restricted cell populations from seven glioma cell lines were isolated and profiled for miRNA expression. Statistical analyses revealed a set of miRNAs common to all seven glioma cell lines that were significantly down regulated in the migrating cell population relative to cells in the migration-restricted population. Among the down-regulated miRNAs, miR-23b has been reported to target potential drivers of cell migration and invasion in other cell types. Over-expression of miR-23b significantly inhibited glioma cell migration and invasion. A bioinformatics search revealed a conserved target site within the 3' untranslated region (UTR) of Pyk2, a non-receptor tyrosine kinase previously implicated in the regulation of glioma cell migration and invasion. Increased expression of miR-23b reduced the protein expression level of Pyk2 in glioma cells but did not significantly alter the protein expression level of the related focal adhesion kinase FAK. Expression of Pyk2 via a transcript variant missing the 3'UTR in miR-23b-expressing cells partially rescued cell migration, whereas expression of Pyk2 via a transcript containing an intact 3'UTR failed to rescue cell migration.
CONCLUSIONS/SIGNIFICANCE: Reduced expression of miR-23b enhances glioma cell migration in vitro and invasion ex vivo via modulation of Pyk2 protein expression. The data suggest that specific miRNAs may regulate glioma migration and invasion to influence the progression of this disease.
胶质母细胞瘤(GB)是最常见和最致命的原发性脑肿瘤。由于疾病的高度侵袭性,临床预后仍然很差,基本上是姑息性的。为了限制恶性胶质瘤细胞的扩散,需要更深入地了解驱动胶质瘤侵袭的分子机制。
方法/主要发现:我们通过比较迁移和限制迁移的人胶质母细胞瘤细胞的匹配大规模全基因组 miRNA 表达谱,研究了 miRNA 差异表达在胶质瘤侵袭中的潜在作用。从 7 种胶质瘤细胞系中分离出迁移和限制迁移的细胞群体,并对其 miRNA 表达进行了分析。统计分析显示,在所有 7 种胶质瘤细胞系中,一组 miRNA 共同下调,与限制迁移的细胞群体相比,这些 miRNA 在迁移细胞群体中显著下调。在下调的 miRNA 中,miR-23b 已被报道在其他细胞类型中靶向细胞迁移和侵袭的潜在驱动因子。过表达 miR-23b 显著抑制了胶质瘤细胞的迁移和侵袭。生物信息学搜索显示,Pyk2 的 3'非翻译区(UTR)内存在一个保守的靶位点,Pyk2 是非受体酪氨酸激酶,先前被认为参与调节胶质瘤细胞的迁移和侵袭。miR-23b 的表达增加降低了胶质瘤细胞中 Pyk2 的蛋白表达水平,但对相关粘着斑激酶 FAK 的蛋白表达水平没有显著影响。在表达 miR-23b 的细胞中,通过缺失 3'UTR 的转录变体表达 Pyk2 部分挽救了细胞迁移,而表达包含完整 3'UTR 的 Pyk2 转录变体则未能挽救细胞迁移。
结论/意义:miR-23b 的表达降低通过调节 Pyk2 蛋白表达增强了胶质瘤细胞在体外的迁移和侵袭能力,并在体外侵袭。数据表明,特定的 miRNA 可能调节胶质瘤的迁移和侵袭,从而影响疾病的进展。